More on EpiPens

Just a note to say those following the EpiPen discussions/debates might find the article “Reverse Voxsplaining: Drugs vs. Chairs” of interest. Author Scott Alexander makes some comparisons between the pricing of EpiPens and the pricing of chairs and in the process demonstrates just how absurd our regulatory system is. But then, you already knew that, didn’t you?



Categories: Big Pharma, Health

13 replies

  1. That article pretty much sums up the diabolical institutional problem that has NOTHING to do with medicine.

    • “Diabolical” pretty well sums it up. I thought the author did a great job of explaining/demonstrating what a colossal mess we have — especially for readers who, previously, might not have fully comprehended the problem.

  2. And I’m sure by now you’ve heard about Mylan’s launch of a generic EpiPen: Mylan Tries Again to Quell Pricing Outrage by Offering Generic EpiPen. Just when you thought the waters couldn’t be any more muddied.

      • There’s competition, but apparently there have been ongoing problems with creating a simple, easy-to-use device that delivers the proper dose every time. And I wouldn’t bet my life on a device from an online company/brand not even mentioned by the National Institutes of Health as one of the brands available in the US:

        There are 3 brands of autoinjectors available in the United States, but they are not interchangeable with respect to training and the way they are used. Given that anaphylaxis may not occur very often at any one location, it can be hard to remember how to use different devices. Patients often forget how to use them within 3 months,2 and many health professionals have never been trained to use them at all.

        EpiPen is the most commonly used device, although it has occasionally been misused when people hold it upside down, press, and inject their thumb or when a child gains access to the device and presses the wrong end. Both situations have been reported to ISMP; most recently a thumb injection by a nurse was reported. Auvi-Q is another brand of autoinjector. It may be easier to use than the EpiPen, because it provides digital voice instructions and the needle retracts to lessen the risk of a needlestick injury. A generic autoinjector from Lineage Pharmaceuticals, which costs about 20% less than the other brands, is more difficult to use. The product will not be familiar to those who currently know how to use one of the other autoinjectors. Also, we recently informed Lineage Pharmaceuticals that its pen lacks a barcode, an issue that the company promised to address.

  3. I have been following it closely, few things make me this furious…

  4. The latest wrinkle? Here in Denver people are starting to list their EpiPens for sale on Craigslist.

"Opinion is the medium between knowledge and ignorance." ~ Plato

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: